相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1
Aris Hayashida et al.
NEUROBIOLOGY OF AGING (2021)
PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan
Kensuke Daida et al.
NEUROBIOLOGY OF AGING (2021)
Analysis of HeterozygousPRKNVariants and Copy-Number Variations in Parkinson's Disease
Eric Yu et al.
MOVEMENT DISORDERS (2021)
Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk
Steven J. Lubbe et al.
HUMAN MOLECULAR GENETICS (2021)
High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies
Kenji Tagai et al.
NEURON (2021)
The Cell Biology of LRRK2 in Parkinson's Disease
Ahsan Usmani et al.
MOLECULAR AND CELLULAR BIOLOGY (2021)
A Novel SNCA A30G Mutation Causes Familial Parkinson's Disease
Hui Liu et al.
MOVEMENT DISORDERS (2021)
Clinical manifestations of Parkinson's disease harboring VPS35 retromer complex component p.D620N with long-term follow-up
Mayu Ishiguro et al.
PARKINSONISM & RELATED DISORDERS (2021)
Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
Dongbing Lai et al.
ANNALS OF NEUROLOGY (2021)
Genetic background influences LRRK2-mediated Rab phosphorylation in the rat brain
Kaela Kelly et al.
BRAIN RESEARCH (2021)
VPS13D promotes peroxisome biogenesis
Heather A. Baldwin et al.
JOURNAL OF CELL BIOLOGY (2021)
VPS13D bridges the ER to mitochondria and peroxisomes via Miro
Andres Guillen-Samander et al.
JOURNAL OF CELL BIOLOGY (2021)
Genotype-Phenotype Relations for the Atypical Parkinsonism Genes: MDSGene Systematic Review
Christina Wittke et al.
MOVEMENT DISORDERS (2021)
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
Ying Fan et al.
ACTA NEUROPATHOLOGICA (2021)
Enhancer release and retargeting activates disease-susceptibility genes
Soohwan Oh et al.
NATURE (2021)
Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model
Nicole K. Polinski et al.
PLOS ONE (2021)
Rapid motor progression of Parkinson's disease associates with clinical and genetic variants
Ling-Xiao Cao et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2021)
Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
PINK1-Parkin signaling in Parkinson's disease: Lessons from Drosophila
Yuzuru Imai
NEUROSCIENCE RESEARCH (2020)
Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease
Akio Mori et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan
Yuanzhe Li et al.
JOURNAL OF HUMAN GENETICS (2020)
The Parkinson's Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network
Alexandra Beilina et al.
CELL REPORTS (2020)
Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans A Genome-Wide Association Study
Jia Nee Foo et al.
JAMA NEUROLOGY (2020)
Mutation screening and burden analysis of VPS13C in Chinese patients with early-onset Parkinson's disease
Xiaojing Gu et al.
NEUROBIOLOGY OF AGING (2020)
The In Situ Structure of Parkinson's Disease-Linked LRRK2
Reika Watanabe et al.
CELL (2020)
GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study
Hong-xu Pan et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Comprehensive assessment of PINK1 variants in Parkinson's disease
Lynne Krohn et al.
NEUROBIOLOGY OF AGING (2020)
A novelSNCAE83Q mutation in a case of dementia with Lewy bodies and atypical frontotemporal lobar degeneration
Alifiya Kapasi et al.
NEUROPATHOLOGY (2020)
LRRK2 and Rab10 coordinate macropinocytosis to mediate immunological responses in phagocytes
Zhiyong Liu et al.
EMBO JOURNAL (2020)
Structure of LRRK2 in Parkinson's disease and model for microtubule interaction
C. K. Deniston et al.
NATURE (2020)
Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson ' s disease
Kenya Nishioka et al.
PARKINSONISM & RELATED DISORDERS (2020)
LRRK2 mediates tubulation and vesicle sorting from lysosomes
Luis Bonet-Ponce et al.
SCIENCE ADVANCES (2020)
Analysis of common and rare VPS13C variants in late-onset Parkinson disease
Uladzislau Rudakou et al.
NEUROLOGY-GENETICS (2020)
Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features
Aya Ikeda et al.
MOVEMENT DISORDERS (2019)
Tau aggregation and seeding analyses of two novel MAPT variants found in patients with motor neuron disease and progressive parkinsonism
Sachiko Nakayama et al.
NEUROBIOLOGY OF AGING (2019)
Antibodies against alpha-synuclein: tools and therapies
Nishant N. Vaikath et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms
Cornelis Blauwendraat et al.
MOVEMENT DISORDERS (2019)
Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease
Michael X. Henderson et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patients
Daniel Ysselstein et al.
NATURE COMMUNICATIONS (2019)
Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson's disease
Hiroshi Ichinose et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
The genetics of Parkinson disease
Hao Deng et al.
AGEING RESEARCH REVIEWS (2018)
Recessive mutations in >VPS13D cause childhood onset movement disorders
Julie Gauthier et al.
ANNALS OF NEUROLOGY (2018)
Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects
Eunju Seong et al.
ANNALS OF NEUROLOGY (2018)
Rab GTPases and Membrane Trafficking in Neurodegeneration
Ferdi Ridvan Kiral et al.
CURRENT BIOLOGY (2018)
Marked Reduction in the Striatal Dopamine Transporter Uptake During the Early Stage of Motor Symptoms in Patients with the MAPT N279K Mutation
Haruka Takeshige et al.
INTERNAL MEDICINE (2018)
GCH1 mutations in dopa-responsive dystonia and Parkinson's disease
Hiroyo Yoshino et al.
JOURNAL OF NEUROLOGY (2018)
Neuropathology of Autonomic Dysfunction in Synucleinopathies
Elizabeth A. Coon et al.
MOVEMENT DISORDERS (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Association analyses of variants of SIPA1L2, MIR4697, GCH1, VPS13C, and DDRGK1 with Parkinson's disease in East Asians
Ming Zou et al.
NEUROBIOLOGY OF AGING (2018)
Reversible Conformational Conversion of alpha-Synuclein into Toxic Assemblies by Glucosylceramide
Friederike Zunke et al.
NEURON (2018)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genetic analysis of TMEM230 in Japanese patients with familial Parkinson's disease
Silvio A. Conedera et al.
PARKINSONISM & RELATED DISORDERS (2018)
VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites
Nikit Kumar et al.
JOURNAL OF CELL BIOLOGY (2018)
LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
Tomoya Eguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A Meta-Analysis of alpha-Synuclein Multiplication in Familial Parkinsonism
Adam Book et al.
FRONTIERS IN NEUROLOGY (2018)
Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations
Masashi Takanashi et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Neuropathology of Genetic Synucleinopathies With Parkinsonism: Review of the Literature
Susanne A. Schneider et al.
MOVEMENT DISORDERS (2017)
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model
Tetsuhiro Kikuchi et al.
NATURE (2017)
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Diana Chang et al.
NATURE GENETICS (2017)
Homozygous alpha-synuclein p.A53V in familial Parkinson's disease
Hiroyo Yoshino et al.
NEUROBIOLOGY OF AGING (2017)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
Laurie A. Robak et al.
BRAIN (2017)
Tau in physiology and pathology
Yipeng Wang et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Loss of VPS1 3C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy
Suzanne Lesage et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Survival and dementia in GBA-associated Parkinson's disease: The mutation matters
Roberto Cilia et al.
ANNALS OF NEUROLOGY (2016)
Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson's Disease
Chung-Han Hsieh et al.
CELL STEM CELL (2016)
A53T in a parkinsonian family: a clinical update of the SNCA phenotypes
Nicola Tambasco et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study
Joanne Trinh et al.
LANCET NEUROLOGY (2016)
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links
Tim Moors et al.
MOVEMENT DISORDERS (2016)
FBXO7 mutations in Parkinson's disease and multiple system atrophy
Silvio Conedera et al.
NEUROBIOLOGY OF AGING (2016)
Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease
Gang Wang et al.
PARKINSONISM & RELATED DISORDERS (2016)
Identification of VPS13C as a Galectin-12-Binding Protein That Regulates Galectin-12 Protein Stability and Adipogenesis
Ri-Yao Yang et al.
PLOS ONE (2016)
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Ziv Gan-Or et al.
AUTOPHAGY (2015)
LRRK2 Facilitates tau Phosphorylation through Strong Interaction with tau and cdk5
Mary R. Shanley et al.
BIOCHEMISTRY (2015)
Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17
Kensaku Kasuga et al.
JOURNAL OF HUMAN GENETICS (2015)
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study
Manabu Funayama et al.
LANCET NEUROLOGY (2015)
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation
Aoife P. Kiely et al.
MOLECULAR NEURODEGENERATION (2015)
Dopa-responsive dystonia-clinical and genetic heterogeneity
Subhashie Wijemanne et al.
NATURE REVIEWS NEUROLOGY (2015)
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson's Disease
Alicia M. Pickrell et al.
NEURON (2015)
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease
Lorraine V. Kalia et al.
JAMA NEUROLOGY (2015)
Cohen Syndrome-associated Protein COH1 Physically and Functionally Interacts with the Small GTPase RAB6 at the Golgi Complex and Directs Neurite Outgrowth
Wenke Seifert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation
Mika H. Martikainen et al.
NEUROLOGY-GENETICS (2015)
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
Ariadna Recasens et al.
ANNALS OF NEUROLOGY (2014)
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers
Niccolo E. Mencacci et al.
BRAIN (2014)
A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific β-Tubulin Isoforms Regulates Tubulin Acetylation
Bernard M. H. Law et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Prevalence of Parkinson's Disease: A Systematic Review and Meta-analysis
Tamara Pringsheim et al.
MOVEMENT DISORDERS (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease
Yuanzhe Li et al.
NEUROBIOLOGY OF AGING (2014)
EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population
Kenya Nishioka et al.
PARKINSONISM & RELATED DISORDERS (2014)
α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation
Jacqueline Burre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
G51D α-Synuclein mutation causes a novel Parkinsonian-pyramidal syndrome
Suzanne Lesage et al.
ANNALS OF NEUROLOGY (2013)
Chorein, the protein responsible for chorea-acanthocytosis, interacts with β-adducin and β-actin
Nari Shiokawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Prion-like spreading of pathological α-synuclein in brain
Masami Masuda-Suzukake et al.
BRAIN (2013)
A case of -synuclein gene duplication presenting with head-shaking movements
Kaori Itokawa et al.
MOVEMENT DISORDERS (2013)
Skin sympathetic fiber α-synuclein deposits A potential biomarker for pure autonomic failure
Vincenzo Donadio et al.
NEUROLOGY (2013)
A NOVEL α-SYNUCLEIN MISSENSE MUTATION IN PARKINSON DISEASE
Christos Proukakis et al.
NEUROLOGY (2013)
LRRK2 Parkinson disease mutations enhance its microtubule association
Lauren R. Kett et al.
HUMAN MOLECULAR GENETICS (2012)
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
Kelvin C. Luk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
Debby Tsuang et al.
NEUROLOGY (2012)
LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis
Samer Matta et al.
NEURON (2012)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
CELL (2011)
Vacuolar Protein Sorting Protein 13A, TtVPS13A, Localizes to the Tetrahymena thermophila Phagosome Membrane and Is Required for Efficient Phagocytosis
Haresha S. Samaranayake et al.
EUKARYOTIC CELL (2011)
Cohen Syndrome-associated Protein, COH1, Is a Novel, Giant Golgi Matrix Protein Required for Golgi Integrity
Wenke Seifert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lysosomal Storage Disorders and Parkinson's Disease: Gaucher Disease and Beyond
Tamar Shachar et al.
MOVEMENT DISORDERS (2011)
Rapid Screening of ATP13A2 Variant with High-Resolution Melting Analysis
Manabu Funayama et al.
MOVEMENT DISORDERS (2010)
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burre et al.
SCIENCE (2010)
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients
I. Trender-Gerhard et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Expanding the Clinical Phenotype of SNCA Duplication Carriers
Kenya Nishioka et al.
MOVEMENT DISORDERS (2009)
Neuropathology of Parkinson's Disease with the R1441G Mutation in LRRK2
Jose-Felix Marti-Masso et al.
MOVEMENT DISORDERS (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes
Kazuko Hasegawa et al.
PARKINSONISM & RELATED DISORDERS (2009)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Myocardial 123Metaiodobenzylguanidine uptake in genetic Parkinson's disease
Aldo Quattrone et al.
MOVEMENT DISORDERS (2008)
Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia
T. Obi et al.
NEUROLOGY (2008)
Invited Article: Nervous system pathology in sporadic Parkinson disease
Heiko Braak et al.
NEUROLOGY (2008)
Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia
Kenta Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy
J. Q. Trojanowski et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
Christine Klein et al.
LANCET NEUROLOGY (2007)
Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease
J Mitsui et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Clinical heterogeneity of α-synuclein gene duplication in Parkinson's disease
K Nishioka et al.
ANNALS OF NEUROLOGY (2006)
Clinical and biochemical correlates of insoluble α-synuclein in dementia with Lewy bodies
J Klucken et al.
ACTA NEUROPATHOLOGICA (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA)
I Mikolaenko et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications
M Farrer et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
Analysis of the human VPS13 gene family
A Velayos-Baeza et al.
GENOMICS (2004)
Gaucher disease: complexity in a simple disorder
E Sidransky
MOLECULAR GENETICS AND METABOLISM (2004)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
Neuropathology provides clues to the pathophysiology of Gaucher disease
KD Wong et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
DW Miller et al.
NEUROLOGY (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport
J Kolehmainen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)
M Segawa et al.
ANNALS OF NEUROLOGY (2003)
Clinical features of frontotemporal dementia due to the intronic tau 10+16 mutation
JC Janssen et al.
NEUROLOGY (2002)
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
M Funayama et al.
ANNALS OF NEUROLOGY (2002)
A conserved sorting-associated protein is mutant in chorea-acanthocytosis
L Rampoldi et al.
NATURE GENETICS (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Neurodegeneration with brain iron accumulation, type 1 is characterized by α-, β-, and γ-synuclein neuropathology
JE Galvin et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Accumulation of insoluble α-synuclein in dementia with Lewy bodies
BCV Campbell et al.
NEUROBIOLOGY OF DISEASE (2000)
Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
K Arima et al.
NEUROLOGY (2000)
分享论文
